The Hague, 26 July 2017 — The International Pharmaceutical Federation (FIP) announced today the resignation of Luc Besançon as Chief Executive Officer effective 1 November, 2017. Mr Besançon has decided to pursue other leadership roles in the global health arena.

Dr Carmen Peña, President of FIP, paid tribute to Mr Besançon saying “Luc resumed the responsibilities as CEO at a time of significant challenges after the unexpected passing of Mr Ton Hoek. During his tenure, Luc effectively led development of new member services and strengthened important relationships with key global health stakeholders such as the WHO. He has been a tremendous asset to FIP, and we wish him the very best."

Speaking about his time at the federation, Mr. Besançon said “It has been my great privilege and pleasure to have worked with so many inspirational volunteers, whose passion for our profession is the strongest asset of FIP. Key projects preparing FIP for a bright future are now well engaged. As I am considering the next step in my career, it seems that this would be the appropriate time for me to resign from my position as the FIP CEO.”

President Peña has formed a transition team to guide the global search for the new FIP CEO while maintaining a stable and effective organisation. Details of the posted job announcement can be accessed at https://www.fip.org/vacancies.